2023 annual financial data
bioAffinity Technologies 2023 Operating margin
Direct answer
Operating margin was -314.89%.
Operating income was -7,973,000 USD and net income was -7,937,000 USD.
Operating cash flow was -6,037,806 USD.
Get free bioAffinity Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,532,000 USD
- Operating income
- -7,973,000 USD
- Net income
- -7,937,000 USD
- Operating cash flow
- -6,037,806 USD